Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Nihon Kyobu Shikkan Gakkai Zasshi|January 1, 1992
[Assessment of alveolar epithelial permeability in progressive systemic sclerosis (PSS) using 99mTc-DTPA (diethylene triamine penta acetate) aerosol inhalation]A Nakano, E Yamaguchi, S Naitoh, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1987
Comparison of antinicotinic activity by neosurugatoxin and the structurally related compoundsS Yamada, Y Kagawa, N Takayanagi, et al.
The Tohoku Journal of Experimental Medicine|May 1, 1987
Immunoenzymatic studies of ornithine transcarbamylase (OTC) in liver of patients with OTC deficiency by enzyme linked immunosorbent assay (ELISA)K Oyanagi, K Tsubakihara, Y Itakura, et al.
Bone Marrow Transplantation|October 19, 2001
Ulcerative colitis after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphomaK Koike, K Kohda, T Kuga, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|May 1, 1996
[Clinical study of ten cases with acute abdomen after eating raw firefly squid (Watasenia scintillans, Hotaruika), which are probably due to type X larvae of the suborder spirurina]S Aoyama, Y Hinoue, H Takahashi, et al.
European Journal of Pediatrics|February 1, 1981
Uridine diphosphate galactose 4-epimerase deficiencyK Oyanagi, F Nakata, S Hirano, et al.
The Japanese Journal of Antibiotics|January 1, 1987
[General pharmacological studies on isepamicin sulfate (HAPA-B)]K Shibata, I Mita, Y Shinoda, et al.
Liver|June 1, 1988
Simultaneous detection of epidermal growth factor receptor (EGF-R), epidermal growth factor (EGF) and ras p21 in cholangiocarcinoma by an immunocytochemical methodA Nonomura, G Ohta, Y Nakanuma, et al.
Journal of Computer Assisted Tomography|May 1, 1988
Calcification in caval membrane causing primary Budd-Chiari syndrome: CT demonstrationA Kobayashi, O Matsui, T Takashima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1993
[NEO-MACOP-B chemotherapy for the treatment of advanced-stage aggressive non-Hodgkin's lymphoma]K Kohda, A Tsuji, N Takayanagi, et al.
Pageof 8